


















bioworld: the daily biopharmaceutical and medical technology news source





















 















bioworld. link to homepage.





bioworldbioworld medtechbioworld asiabioworld sciencedata snapshotsbioworldbioworld medtechinfographics: dynamic digital data analysisspecial reportsinfographics: dynamic digital data analysistrump administration impactsbiopharma m&a scorecardbioworld 2024 reviewbioworld medtech 2024 reviewbioworld science 2024 reviewwomen's healthchina's glp-1 landscapepfa re-energizes afib marketchina car talzheimer's diseaseisraelrise of obesityradiopharmaceuticalsbiosimilarsagingivds on the risecoronavirusartificial intelligence


bioworld. link to homepage.






sign in


sign out


my account



subscribebioworld - sunday, february 16, 2025bioworldbioworld medtechbioworld asiabioworld science
bioworld

trump administration an existential threat to science, warns aaas chiefthe scientific establishment has launched a fight back against the trump administration and the slew of executive orders that threaten to dismantle research funding, with a...

more in bioworld

bioworld medtech

allurion cleared to resume sale of swallowable gastric balloon in franceallurion technologies inc. is cleared by regulators in france to resume sales of its swallowable gastric balloon to treat obesity, in the country. last summer, the company...

more in bioworld medtech

bioworld science

insights into extracellular matrix are metastasis mapnew research has uncovered a complex interplay between extracellular matrix (ecm) structure and the transcriptional responses of cancer cells, showing how they alter their...

more in bioworld science

bioworld asia

mixed reactions from asia on biotech implications of trump 2.0“this current administration is like nothing that we've seen before,” said a managing partner of a global venture capital firm who spoke to bioworld on the condition of...

more in bioworld asia

bioworld insider podcastthe bioworld insider podcast is a monthly dive into the business and science of drug development. conversations with ceos and bioworld analysts in the past 12 months have included a wide range of chats with experts who are shaping the future.listen nowbioworldtoday's newsanalysis and data insightclinicaldata snapshotsdeals and m&afinancingsnewco newsopinionregulatorysciencebioworld medtechtoday's newsclinicaldata snapshotsdeals and m&afinancingsnewco newsopinionregulatorysciencebioworld asiatoday's newsanalysis and data insightaustraliachinaclinicaldeals and m&afinancingsnewco newsregulatorysciencebioworld sciencetoday's newsbiomarkerscancerconferencesendocrine/metabolicimmuneinfectionneurology/psychiatricpatentsmoreaboutadvertise with bioworldarchivesarticle reprints and permissionscontact uscookie policycopyright noticedata methodologyinfographics: dynamic digital data analysispodcastsprivacy policyshare your news with bioworldstaffterms of usetopic alertsfollow us
copyright ©2025. all rights reserved. design, cms, hosting & web development :: epublishingcookie settings


